Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALZ-801 in early Alzheimer's disease with APOE4 carriers
NCT04693520Phase 2Completed
- Sponsor
- Alzheon, Inc.
- Start
- Sep 2020
- Primary completion
- Jun 2023
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of valiltramiprosate in Alzheimer's disease (AD), sponsored by Alzheon, Inc.. Started Sep 2020; status: completed.
02
Drugs
valiltramiprosate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04693520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04693520.